TMO

Thermo Fisher Scientific

TMO · Salud · Next earnings: 21 Oct 2026 · Before the open · Q3 2026

Relevance 50/100 · Minor

1-year price history

Source: Yahoo Finance
- Calculating change...

The chart uses daily closes adjusted by the available provider. There may be delays, gaps or differences versus the official source.

Company

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally.

What the market expects

ConsensusPrior-year EPS
EPS6.405.79
Revenue11,950,278,450—

21 analysts

How expectations have moved

Expectations: High

Expectativas elevadas: la acción acumula +26% en 90 días y cotiza a un 5% de su máximo de 52 semanas. Superar el consenso no garantiza una subida — el mercado puede tener ya descontado un buen resultado.

Stock, 90 days
+26.2%

Prior behaviour

Average absolute move
5.5%
Largest move
9.2%
releases with a move larger than 5%
50%
beat the EPS consensus in
4 of the last 4
Quarter Date 1-session move Surprise EPS
Jun 2026 23 Jul 2026 +8.7% +5.6%
Mar 2026 23 Apr 2026 -9.2% +4.6%
Dec 2025 29 Jan 2026 -2.6% +2.2%
Sep 2025 22 Oct 2025 +1.6% +5.3%

Historical moves describe typical magnitude, not a future direction.

Expected move

±7.1% (options)

“±X%” is the typical move size, not a forecast of direction.

Stock situation

Price
662.06
30 days
+7.9%
90 days
+26.2%
Distance to 52-week high
-4.7%
Market cap
242,768,675,000

Metrics to watch

Relevance breakdown
market_cap
14.4
analyst_coverage
8.4
estimate_revisions
0.0
recent_price_move
3.1
historical_earnings_vol
8.3
sector_importance
4.0
recent_news_coverage
7.0

Disclaimer

Radar Acciones provides information and analysis tools, not personalised investment advice. Consensus and expectations data describe the setup around an event with objective figures; they must never be read as a forecast of direction or price.